Delivery Order SPE2DB22D1002-SPE2DB25FKUR5

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $37,711.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dapagliflozin 10 mg tablets, a medication used to manage diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,071.05 firm fixed-price delivery order is for the supply of Dapagliflozin 5 mg tablets, a medication used to treat diabetes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,916.42 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.67 firm fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a medication used for the treatment of Type 2 diabetes. The contract has an ultimate completion date of October 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $9,503.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dapagliflozin 10 mg tablets, a medication used to treat diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,726.16 firm fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a medication used to manage diabetes. The contract has an ultimate completion date of September 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $10,266.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dapagliflozin 10 mg tablets, a medication used in the management of diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,497.70 firm fixed-price delivery order is for the supply of 4,567,957,147 units of dapagliflozin 10 mg tablets, a medication used to treat diabetes. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 between AmerisourceBergen...
This federal contract award, valued at $1,439.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The award is a Delivery Order placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,376.58 firm fixed-price delivery order is for the supply of 4567408209 - DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used in the management of diabetes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKUR5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,100.24 firm fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a medication used in diabetes management.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities across multiple therapeutic areas, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, plays a crucial role in supplying essential pharmaceutical and medical products to military treatment facilities, veterans' healthcare programs, and other federal medical institutions served by the DLA.

Generated 5/20/25, 1:56 PM